1. Home
  2. BGSF vs SCLX Comparison

BGSF vs SCLX Comparison

Compare BGSF & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGSF Inc.

BGSF

BGSF Inc.

HOLD

Current Price

$6.07

Market Cap

63.4M

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$7.32

Market Cap

52.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGSF
SCLX
Founded
2007
2011
Country
United States
United States
Employees
N/A
30
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.4M
52.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
BGSF
SCLX
Price
$6.07
$7.32
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$9.00
N/A
AVG Volume (30 Days)
24.1K
28.1K
Earning Date
03-11-2026
04-06-2026
Dividend Yield
32.36%
N/A
EPS Growth
67.37
N/A
EPS
N/A
N/A
Revenue
$272,499,000.00
N/A
Revenue This Year
$4.67
N/A
Revenue Next Year
N/A
$749.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.91
$0.18
52 Week High
$8.20
$34.27

Technical Indicators

Market Signals
Indicator
BGSF
SCLX
Relative Strength Index (RSI) 54.39 37.25
Support Level $5.93 $4.56
Resistance Level $6.38 $7.50
Average True Range (ATR) 0.26 0.72
MACD -0.03 0.00
Stochastic Oscillator 39.77 4.62

Price Performance

Historical Comparison
BGSF
SCLX

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: